Shenzhen Glory Medical Co.,Ltd.

SZSE:002551.SZ

3.99 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 1,192.8871,275.711,790.2962,267.2941,530.821,630.4322,006.4771,946.051,666.3191,166.777730.901421.319348.428270.036208.511138.068116.371
Cost of Revenue 995.2831,053.8331,427.3571,572.5851,2011,228.4561,533.7321,471.0591,229.581836.505508.369260.761243.138162.733122.26779.53470.724
Gross Profit 197.604221.877362.939694.709329.82401.976472.745474.991436.738330.272222.532160.558105.289107.30386.24358.53445.648
Gross Profit Ratio 0.1660.1740.2030.3060.2150.2470.2360.2440.2620.2830.3040.3810.3020.3970.4140.4240.392
Reseach & Development Expenses 40.07448.18252.36861.16847.88946.23650.71645.99641.49331.03920.77311.3277.745.8245.3473.6244.105
General & Administrative Expenses 40.71940.17543.06639.29631.74624.17941.58733.24743.6522.74217.40914.47912.7528.01211.6967.623.951
Selling & Marketing Expenses 24.09924.68371.90989.63864.60667.13369.92167.81559.26149.96134.87125.60818.79713.67110.9127.7356.084
SG&A 64.81864.858114.975128.93496.35291.312111.507101.062102.91172.70252.2840.08631.54921.68222.60815.35510.035
Other Expenses -6.421115.382100.586121.35958.97430.128-0.1027.7914.5252.4857.2813.321.6950.6950.48-0.1791.314
Operating Expenses 217.492228.423267.929311.461203.215197.415228.268245.116238.799176.234127.3289.89168.21749.09339.69526.05820.119
Operating Income -121.2230.791126.726370.299141.037122.835225.411154.382167.83131.28188.59569.22750.34557.14246.74428.75823.38
Operating Income Ratio -0.1020.0010.0710.1630.0920.0750.1120.0790.1010.1130.1210.1640.1440.2120.2240.2080.201
Total Other Income Expenses Net -6.421-385.166-37.675-1.825-70.212-51.598-19.169-67.722-25.605-20.6540.5571.8814.968-0.3730.677-3.898-0.835
Income Before Tax -127.645-384.37589.05368.47470.824152.963225.309162.152172.335133.38495.7772.54752.0457.83747.22528.57924.694
Income Before Tax Ratio -0.107-0.3010.050.1630.0460.0940.1120.0830.1030.1140.1310.1720.1490.2140.2260.2070.212
Income Tax Expense 33.179-56.4721.031-1.475-5.618.24836.13425.82928.88422.38118.28512.9047.72811.0617.7083.9582.574
Net Income -148.889-327.90288.02369.94959.75997.711175.16114.154119.056102.15773.75658.33244.15846.39339.87924.11922.012
Net Income Ratio -0.125-0.2570.0490.1630.0390.060.0870.0590.0710.0880.1010.1380.1270.1720.1910.1750.189
EPS -0.18-0.390.10.460.0850.150.260.170.180.160.110.090.0710.0950.0840.0540.058
EPS Diluted -0.18-0.390.10.440.0710.150.260.170.180.150.110.090.0710.0950.0840.0540.058
EBITDA 89.771125.791203.404438.187180.624271.72279.571272.391245.514198.178138.275102.31768.75570.79751.62135.5928.998
EBITDA Ratio 0.0750.0990.1140.1930.1180.1670.1390.140.1470.170.1890.2430.1970.2620.2480.2580.249